Full Text View
Tabular View
No Study Results Posted
Related Studies
Prenatal Steroids for Treatment of Congenital Cystic Adenomatoid Malformations (CCAM) (CCAM Steroids)
This study has been withdrawn prior to enrollment.
( Recruitment has been poor. Study drug is being offered as part of standard care of women carrying a pregnancy diagnosed with CCAM )
Study NCT00670956   Information provided by University of California, San Francisco

First Received on April 30, 2008.   Last Updated on September 1, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Congenital Abnormalities
Cystic Adenomatoid Malformation of Lung, Congenital
More general conditions related to this trial
Lung Diseases
Respiratory System Abnormalities
Respiratory Tract Diseases
Interventions listed in this trial
Betamethasone
Placebo
Additional drug interventions recognized in this trial
Betamethasone sodium phosphate
Betamethasone-17,21-dipropionate
More general drug interventions related to this trial
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
University of California, San Francisco
Children's Hospital Medical Center, Cincinnati
Children's Hospital of Philadelphia


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services